Der er ingen indikation af, at effekt eller sikkerhed af FIRMAGON behandling påvirkes af dannelse af antistof efter et års behandling.
There is no indication that the efficacy or safety of FIRMAGON treatment is affected by antibody formation after one year of treatment.